Emerson Christopher Phd Los Angeles, CA - 90048

Emerson Christopher Phd is categorized under Outpatient Services in Los Angeles, CA and active since 2011.

Emerson Christopher Phd was established in 2011, and today employs 1 to 4, earning Unknown per year. This is a Outpatient Services business, which does work in the B2C market, and is classified as a Outpatient Services, under code number 621420 by the NAICS.

If you are seeking more information, feel free to contact Chris Emerson at the company’s single location by writing to 450 North Robertson Boulevard Floor 2, Los Angeles, California CA 90048 or by phoning (310) 550-4560. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Emerson Christopher Phd
Contact Person: Chris Emerson
Address: 450 North Robertson Boulevard Floor 2, Los Angeles, California 90048
Phone Number: (310) 550-4560
Website Address: drchrisemerson.com
Annual Revenue (USD): Unknown
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Outpatient Services
SIC Code: 8093
NAICS Code: 621420
Share This Business:

Emerson Christopher Phd was started in 2011 to provide professional Outpatient Services under the SIC code 8093 and NAICS code 621420. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Chris Emerson for inquiries that concern Emerson Christopher Phd by calling the company number (310) 550-4560, as your correspondence is most welcome. Additionally, the physical location of the single location of Emerson Christopher Phd can be found at the coordinates 34.079525,-118.384541 as well as the street address 450 North Robertson Boulevard Floor 2 in Los Angeles, California 90048.

For its online presence, you may visit Emerson Christopher Phd’s website at drchrisemerson.com and engage with its social media outlets through on Twitter and on Facebook.